ALEXANDRIA, Va., June 4 -- United States Patent no. 12,319,674, issued on June 3, was assigned to KING SAUD UNIVERSITY (Riyadh, Saudi Arabia).
"Isatin derivatives" was invented by Ahmed Bari (Riyadh, Saudi Arabia), Saeed Ali Syed (Riyadh, Saudi Arabia) and Mohammad A. Altamimi (Riyadh, Saudi Arabia).
According to the abstract* released by the U.S. Patent & Trademark Office: "A method of treating cancer can include administering one or more of the isatin derivatives to a patient in need thereof. In an embodiment, the cancer is selected from the group consisting of breast cancer, non-small cell lung cancer, renal cancer and melanoma. The isatin derivative is selected from the group consisting of:"
The patent was filed on March 14, 2024, un...